Technical Analysis for INNT - Innovate Biopharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 0.811 -6.78% -0.06
INNT closed down 6.78 percent on Tuesday, November 19, 2019, on 2.15 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical INNT trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Upper Bollinger Band Touch Strength -6.78%
Crossed Above 20 DMA Bullish -7.85%
MACD Bullish Signal Line Cross Bullish -7.85%
Pocket Pivot Bullish Swing Setup -7.85%
Up 3 Days in a Row Strength -7.85%
Up 4 Days in a Row Strength -7.85%
Pocket Pivot Bullish Swing Setup -0.36%
Doji - Bullish? Reversal -0.36%
Wide Bands Range Expansion -0.36%

Older signals for INNT ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Innovate Biopharmaceuticals, Inc., formerly Monster Digital, Inc., is a clinical stage biotechnology company. The Company is focused on developing novel autoimmune and inflammation therapeutic drugs. Its lead drug candidate, larazotide acetate (INN-202) is a tight junction regulator. Its other products include INN-108 and INN-329 (Secretin). The Company’s INN-108 is a novel small molecule comprised of two active parts with anti- inflammatory and immunodulatory properties coupled through an azo bond. The Company is developing INN-108 as a therapeutic for Ulcerative Colitis (UC). Its Secretin stimulated magnetic resonance cholangiopancreatography (MRCP) is a ionizing, radiation-free assessment of the pancreaticobiliary system. The Company has completed a phase II b clinical trial for celiac disease for INN-202. It is developing INN-108 in a phase II trial for inflammatory bowel disorders, mild to moderate UC and a Gastrointestinal (GI) orphan disease.
Medicine Biotechnology Biopharmaceutical Medical Specialties Autoimmune Diseases Inflammation Radiation Inflammatory Bowel Disease Ulcerative Colitis Abdominal Pain Diarrhea Digestive Diseases Colitis Celiac Disease Gastrointestinal Tract
Is INNT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.32
52 Week Low 0.728
Average Volume 208,374
200-Day Moving Average 1.346
50-Day Moving Average 0.9863
20-Day Moving Average 0.8444
10-Day Moving Average 0.8319
Average True Range 0.0775
ADX 27.87
+DI 14.4109
-DI 23.5077
Chandelier Exit (Long, 3 ATRs ) 0.8375
Chandelier Exit (Short, 3 ATRs ) 0.9825
Upper Bollinger Band 0.9075
Lower Bollinger Band 0.7813
Percent B (%b) 0.24
BandWidth 14.945523
MACD Line -0.0398
MACD Signal Line -0.0459
MACD Histogram 0.0061
Fundamentals Value
Market Cap 7.58 Million
Num Shares 9.35 Million
EPS -0.89
Price-to-Earnings (P/E) Ratio -0.91
Price-to-Sales 1.94
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.94
Resistance 3 (R3) 0.95 0.91 0.92
Resistance 2 (R2) 0.91 0.88 0.91 0.91
Resistance 1 (R1) 0.86 0.86 0.85 0.85 0.90
Pivot Point 0.83 0.83 0.82 0.82 0.83
Support 1 (S1) 0.78 0.80 0.76 0.77 0.72
Support 2 (S2) 0.74 0.78 0.74 0.71
Support 3 (S3) 0.69 0.74 0.70
Support 4 (S4) 0.68